Virios Therapeutics, Inc. VIRI
Set alert
0.16 0.00 0.00%
At close · Oct 8
0.143 Day range 0.2068
52-week range unavailable
- Open
- 0.2068
- Prev close
- 0.155
- Mkt cap
- 206.50K
- Vol
- 42.36M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.143
- High
- 0.2068
- Forward P/E
- -0.97
- Beta
- 1.58
- Short ratio
- 0.64
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 11, 2024
- 50-d avg
- 4.51
- 200-d avg
- 7.69
- 1y target
- 3.00
2Y chart
Events in this range
- Aug 10, 2023Earnings: —; estimate -0.07; surprise —%
- Nov 13, 2023Earnings: —; estimate -0.1; surprise —%
- Feb 29, 2024Earnings: —; estimate -0.09; surprise —%
- May 9, 2024Earnings: —; estimate -0.08; surprise —%
- Aug 8, 2024Earnings: —; estimate -0.07; surprise —%
- Oct 9, 2024Split: 1 for 25
Signals (70)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 4, 2024 | 1 year ago |
| SMA: Bearish | Oct 29, 2024 | 2 years ago |
| SMA: Bullish | Oct 24, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 14, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 26, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 11, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 4, 2024 | 2 years ago |
| SMA: Bearish | Aug 22, 2024 | 2 years ago |
| SMA: Bullish | Aug 21, 2024 | 2 years ago |
| MACD: Buy Signal | Aug 16, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 24, 2024 | 2 years ago |
| SMA: Bearish | Jul 19, 2024 | 2 years ago |
| SMA: Bullish | Jul 17, 2024 | 2 years ago |
| MACD: Buy Signal | Jun 5, 2024 | 2 years ago |
| RSI: Oversold | May 20, 2024 | 2 years ago |
| SMA: Bearish | May 9, 2024 | 2 years ago |
| SMA: Bullish | May 8, 2024 | 2 years ago |
| SMA: Bearish | May 3, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 16, 2024 | 2 years ago |
| SMA: Bullish | Mar 22, 2024 | 2 years ago |
| MACD: Buy Signal | Feb 12, 2024 | 2 years ago |
| MACD: Sell Signal | Jan 23, 2024 | 2 years ago |
| SMA: Bearish | Jan 22, 2024 | 2 years ago |
| SMA: Bullish | Jan 9, 2024 | 2 years ago |
| MACD: Buy Signal | Jan 9, 2024 | 2 years ago |
| MACD: Sell Signal | Dec 20, 2023 | 2 years ago |
| SMA: Bearish | Dec 15, 2023 | 2 years ago |
| SMA: Bullish | Dec 14, 2023 | 2 years ago |
| SMA: Bearish | Dec 7, 2023 | 2 years ago |
| SMA: Bullish | Dec 4, 2023 | 2 years ago |
| MACD: Buy Signal | Dec 4, 2023 | 2 years ago |
| MACD: Sell Signal | Nov 27, 2023 | 2 years ago |
| MACD: Buy Signal | Nov 2, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 19, 2023 | 3 years ago |
| RSI: Oversold | Oct 19, 2023 | 3 years ago |
| MACD: Buy Signal | Oct 9, 2023 | 3 years ago |
| MACD: Sell Signal | Oct 5, 2023 | 3 years ago |
| SMA: Bearish | Oct 2, 2023 | 3 years ago |
| MACD: Buy Signal | Sep 14, 2023 | 3 years ago |
| MACD: Sell Signal | Sep 12, 2023 | 3 years ago |
| MACD: Buy Signal | Aug 30, 2023 | 3 years ago |
| RSI: Oversold | Aug 10, 2023 | 3 years ago |
| SMA: Bearish | Aug 7, 2023 | 3 years ago |
| MACD: Sell Signal | Jul 28, 2023 | 3 years ago |
| RSI: Overbought | Jul 14, 2023 | 3 years ago |
| MACD: Buy Signal | Jul 12, 2023 | 3 years ago |
| SMA: Bullish | Jul 6, 2023 | 3 years ago |
| SMA: Bearish | Jul 5, 2023 | 3 years ago |
| MACD: Sell Signal | Jun 21, 2023 | 3 years ago |
| RSI: Overbought | Jun 13, 2023 | 3 years ago |
| RSI: Overbought | May 26, 2023 | 3 years ago |
| MACD: Buy Signal | May 23, 2023 | 3 years ago |
| RSI: Overbought | May 23, 2023 | 3 years ago |
| MACD: Sell Signal | May 17, 2023 | 3 years ago |
| RSI: Overbought | Apr 25, 2023 | 3 years ago |
| RSI: Overbought | Apr 19, 2023 | 3 years ago |
| RSI: Overbought | Apr 12, 2023 | 3 years ago |
| RSI: Overbought | Apr 10, 2023 | 3 years ago |
| SMA: Bullish | Mar 24, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 24, 2023 | 3 years ago |
| RSI: Overbought | Mar 24, 2023 | 3 years ago |
| SMA: Bearish | Mar 15, 2023 | 3 years ago |
| MACD: Sell Signal | Mar 13, 2023 | 3 years ago |
| MACD: Buy Signal | Mar 6, 2023 | 3 years ago |
| RSI: Overbought | Mar 6, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 22, 2023 | 3 years ago |
| MACD: Buy Signal | Feb 17, 2023 | 3 years ago |
| MACD: Sell Signal | Feb 10, 2023 | 3 years ago |
| RSI: Oversold | Dec 9, 2022 | 3 years ago |
| RSI: Oversold | Dec 7, 2022 | 3 years ago |
Key statistics
- Market cap
- 206.50K
- Enterprise value
- 122.01K
- Trailing P/E
- 0.00
- Forward P/E
- -0.97
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.05
- EPS (TTM)
- -5.75
- Beta
- 1.58
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -2.43M
- Total cash
- 3.02M
- Total debt
- 0
- Return on equity
- -119.56%
- Shares outstanding
- 1.33M
- Short % of float
- 1.76%
- 50-day average
- 4.51
- 200-day average
- 7.69
Analyst view
Consensus: buy
Buy
Price target (mean) 3.00 +1835.5% upside
Now 0.155
- Target (low)
- 1.00
- Target (mean)
- 3.00
- Target (high)
- 5.00
Next earnings
Nov 11, 2024
Expected Nov 11, 2024. Consensus EPS estimate -0.05.
Financials — quick view
VIRI Revenue — quarterly 0
VIRI Net income — quarterly -1.05M
VIRI EPS — quarterly -0.05
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 11, 2024 | Sep 1, 2024 | -0.06 | — | — | — |
| Aug 8, 2024 | Jun 1, 2024 | -0.07 | — | — | — |
| May 9, 2024 | Mar 1, 2024 | -0.08 | — | — | — |
| Feb 29, 2024 | Dec 1, 2023 | -0.09 | — | — | — |
| Nov 13, 2023 | Sep 1, 2023 | -0.10 | — | — | — |
| Aug 10, 2023 | Jun 1, 2023 | -0.07 | — | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 19, 2022 | HC Wainwright & Co. | down | Buy | Neutral |
| Dec 14, 2021 | HC Wainwright & Co. | init | — | Buy |
About Virios Therapeutics, Inc.
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- virios.com
News
- Analyzing Virios Therapeutics (NASDAQ:VIRI) & Palatin Technologies (PINK:PTNT)
- 12 Health Care Stocks Moving In Tuesday's After-Market Session
- Why DocuSign Shares Are Trading Higher By Around 6%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Monday's Intraday Session
- Virios Therapeutics, Inc. and Wex Pharmaceuticals, Inc. Announce Business Combination to Form Dogwood Therapeutics, Inc. (Nasdaq: “DWTX”)
- Virios Therapeutics Announces Second Quarter 2024 Financial Results
- Virios Therapeutics to Report Second Quarter 2024 Financial Results on Thursday, August 8, 2024
- Virios Therapeutics Announces Completion of Enrollment in IMC-2 Phase 2 Long-COVID Study Being Conducted by Bateman Horne Center
- Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Why Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Your note
Sign in to keep a note on VIRI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| DUNCAN GREGORY SCOTT | Chief Executive Officer | Purchase | Aug 16, 2023 | 57,461 |
| PRIDGEN WILLIAM L | Director | Purchase | Aug 20, 2023 | 0 |
| WHITLEY RICHARD JAMES | Director | Sale | Dec 7, 2022 | 700 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 1.10% | 210,996 | 291.17K | Jun 29, 2023 |
| Geode Capital Management, LLC | 0.77% | 147,269 | 203.23K | Jun 29, 2023 |
| State Street Corporation | 0.27% | 52,828 | 72.90K | Jun 29, 2023 |
| Susquehanna International Group, LLP | 0.27% | 52,639 | 72.64K | Jun 29, 2023 |
| Renaissance Technologies, LLC | 0.24% | 46,400 | 64.03K | Jun 29, 2023 |
| Citadel Advisors Llc | 0.17% | 33,298 | 45.95K | Jun 29, 2023 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 1.09% | 208,883 | 288.26K | Jun 29, 2023 |
| Fidelity Extended Market Index Fund | 0.70% | 134,121 | 230.69K | May 30, 2023 |
| Fidelity Series Total Market Index Fund | 0.17% | 33,485 | 57.59K | May 30, 2023 |
| Fidelity Total Market Index Fund | 0.08% | 14,707 | 25.30K | May 30, 2023 |
| Fidelity NASDAQ Composite Index Fund | 0.02% | 3,038 | 5.22K | May 30, 2023 |